A529 PRIA Fee Category
PRIA 4 Fee Determination Decision Tree:
Amend Antimicrobial Experimental Use Permit
Below is the fee for your selected Fee Category for Fiscal Years 2020-2021
|Action Code||Description||FY'20 - FY'21 Fee||Decision Time (months)|
|A529||Amendment to Experimental Use Permit; requires data review or risk assessment (2)||$12,001||9|
Do you plan to request either of the following types of waivers?
|50% waiver||You pay ---->>>>>||$6,001|
|75% waiver||You pay ---->>>>>||$3,000|
To pay the fee shown above, go to Paying PRIA Application Fees web page and follow the instructions.
How to submit your application directly to EPA.
|Action Code Interpretation|
An application to amend an Experimental Use Permit (EUP) application for the currently registered uses. The application requires review of the amendment, including data review and/or new risk assessments for the currently registered uses. If new uses are being proposed, then the application would not fall within this category.
All of the inerts used in the product must be either approved or pending with the Agency for the applicable uses.
The Agency will provide the applicant with a pre-decisional determination 2 weeks prior to the PRIA decision review time due date which specifies any label changes that have to be made in order to grant the requested experimental use permit. If the label issues cannot be resolved prior to the PRIA decision review time due date and if a PRIA due date time extension has not been agreed upon, then the Agency will issue to the applicant its regulatory decision with the specific label changes and supporting documentation on or just before the PRIA decision review time due date. At that time the applicant must either (a) agree to all of the label changes and submit a revised label that incorporates all of these label changes; or (b) does not agree with one or more of the label changes and request up to 30 days to reach agreement with the Agency and submit a revised label that incorporates all of the agreed upon label changes, which the Agency has 2 business days to review; or (c) withdraw the application without prejudice.